Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 6Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Blast Crisis 4Unspecified Adult Solid Tumor, Protocol Specific 3Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Gliosarcoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Anemia, Refractory, with Excess of Blasts 2Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1

Interventions

Cyclophosphamide 12Filgrastim 9fludarabine phosphate 8Etoposide 8Dasatinib 7Tacrolimus 6Peripheral Blood Stem Cell Transplantation 6Imatinib Mesylate 5Cytarabine 5sargramostim 4Cyclosporine 4Cord Blood Stem Cell Transplantation 4Carboplatin 4Antilymphocyte Serum 4tanespimycin 3Whole-Body Irradiation 3Vorinostat 3Sirolimus 3Prednisone 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Doxorubicin 3Busulfan 3tipifarnib 2Topotecan 2Thiotepa 2Sunitinib 2Specimen Handling 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Myeloid, Accelerated Phase × tipifarnib × Clear all
NCT00004009 2019-11-07

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

University of Maryland, Baltimore

Phase 1 Completed
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00005967 2013-02-11

Tipifarnib in Treating Patients With Advanced Hematologic Cancer

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡